B3GNT2-IN-1 is a β-1,3-N-acetylglucosaminyltransferase 2 ( B3GNT2 ) inhibitor with an IC 50 of 0.009 μM. B3GNT2-IN-1 is applicable to research related to rheumatoid arthritis, ankylosing spondylitis and psoriasis.
Products | Products > Disease Areas > Psoriasis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Ankylosing Spondylitis | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Skin Inflammation | Products > Disease Areas > Arthritis | Products > Disease Areas > Spinal Disease | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Transmembrane Glycoprotein
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.